A5056813674- Neonatal Health and Biochemistry
- Metabolism and Genetic Disorders
- Congenital Heart Disease Studies
- Neonatal Respiratory Health Research
- Infant Development and Preterm Care
- Infant Nutrition and Health
- Mitochondrial Function and Pathology
- Cystic Fibrosis Research Advances
- Gastroesophageal reflux and treatments
- Child Nutrition and Feeding Issues
- Mechanical Circulatory Support Devices
- Maternal Mental Health During Pregnancy and Postpartum
- Family and Patient Care in Intensive Care Units
- Pharmacological Effects and Toxicity Studies
- Breastfeeding Practices and Influences
- Neurogenetic and Muscular Disorders Research
- Emergency and Acute Care Studies
- Neonatal and Maternal Infections
- Cardiac Structural Anomalies and Repair
- Infant Health and Development
- Prenatal Substance Exposure Effects
University of South Alabama
2023-2024
Women's Hospital
2024
Louisiana State University Health Sciences Center Shreveport
2024
St. Christopher's Hospital for Children
2020-2023
Tianeptine is an opioid receptor agonist that prescribed as antidepressant in many countries. In the United States, tianeptine not approved for medical use because of its potential abuse and addiction. Nonetheless, products containing are easily obtainable marketed dietary supplements. There increasing reports adverse effects fatal toxicities resulting from among adolescents adults. This emerging public health threat could escalate epidemic drive increased newborn perinatal exposure. The...
Abstract Objectives To assess the impact of oral dextrose gel (ODG) treatment on NICU admission rates for hypoglycemic infants in a well-baby nursery. Study design We retrospectively compared newborn at risk hypoglycemia born during intervention period ( n = 3775) with historical controls 655). also primary outcome (NICU admission) and secondary outcomes (exclusive breastfeeding hospital costs) between two periods. Results Following implementation ODG supplementation, admissions dropped from...
Recent data describe an increasing use of extracorporeal membrane oxygenation (ECMO) in neonates with various clinical conditions besides primary respiratory or cardiac diagnoses. Infants underlying genetic disorders characterized by cardiopulmonary failure pose unique management challenges. When pathognomonic dysmorphic features for common diagnoses are not present, the prognosis is uncertain at best when determining ECMO candidacy. Lengthy turnaround times testing often delay definitive...
Abstract Objectives To assess the impact of oral dextrose gel (ODG) treatment on NICU admission rates for hypoglycemic infants in a well-baby nursery. Study Design We retrospectively compared newborn infants, at risk hypoglycemia, born during intervention period (n=3775) with historical controls (n=655). Rates primary outcome (NICU admission) and secondary outcomes (exclusive breastfeeding, hospital costs) were between groups. Results Following implementation ODG supplementation, admissions...
Since the initial deployment of neonatal extracorporeal membrane oxygenation (ECMO) for respiratory failure, use ECMO in this population has diversified. We present a term female infant with carbamoyl phosphate synthetase 1 and partial N-acetylglutamate synthase deficiencies who developed severe hyperammonemia refractory to medical management requiring venoarterial ECMO-driven continuous veno-venous hemodiafiltration ammonia detoxification. This case report illustrates subpopulation where...
A full term boy is delivered vaginally at 38 weeks’ gestation to a 35-year-old gravida 4, para 2 woman with unremarkable prenatal laboratory findings including negative group B Streptococcus findings. The maternal history significant for early neonatal death of male infant from unknown cause 7 years earlier. Pregnancy and delivery are uncomplicated. neonate has birthweight 2,800 g, appropriate gestational age, Apgar scores 8 9 1 5 minutes, respectively. He initially feeding well in the...
Since the initial deployment of neonatal extracorporeal membrane oxygenation (ECMO) for respiratory failure, use ECMO in this population has diversified. We present a term female infant with carbamoyl phosphate synthetase 1 and partial N-acetylglutamate synthase deficiencies who developed severe hyperammonemia refractory to medical management requiring venoarterial ECMO-driven continuous veno-venous hemodiafiltration ammonia detoxification. This case report illustrates subpopulation where...
A 935-g girl with intrauterine growth restriction is born at 29 weeks and 5 days of gestation to a 26-year-old gravida 6, para 2 woman. The pregnancy significant for chronic hypertension treated hydralazine, labor induced preeclampsia which diagnosed on the day delivery. Intrapartum magnesium betamethasone are administered cesarean section performed nonreassuring fetal heart tones. neonate’s Apgar scores 8 1 minutes, respectively, she requires continuous positive airway pressure tachypnea,...